The objective of this proposal is to develop a vascularized immunocompetent tissue as an alternative liver (VITAL)
Active Cooperative Agreement Awarded Last action
- Award ID
- D25AC00239
- Recipient
-
The University Of Texas Southwestern Medical Center UEI YZJ6DKPM4W63
- Awarding agency
-
Interior Business Center
Office of Policy Management and Budget, Department of the Interior
- Obligated
- $14,330,656
Award facts
- Assistance listing
- 93.384 ADVANCED RESEARCH PROJECTS AGENCY for HEALTH (ARPA-H)
- Completion date 40% complete
- Place of performance
- United States
Award details come from USAspending.gov.
Description
The transformative VITAL liver will include suturable blood vessels to enable orthotopic transplantation in patients. In technical area 1 (TA1) we will develop protocols to generate liver cells from blood samples and liver biopsy of patients from various ethnicities and genders to ensure immune competency and demonstrate their liver specific functions. In TA2 at the university of texas southwestern medical center (UTSW) we will develop GLP cell manufacturing processes to scale up the production of liver cells in a cost effective manner using perfusion bioreactor technology. In partnership with the university of california davis (UC davis) good manufacturing practices (GMP) facility we will demonstrate GMP compliant cell manufacturing with validated liver specific functions utilizing the same perfusion bioreactor technology optimized at UTSW. In TA 3 we will use our proprietary BIO printable hydrogels (BIOINKS) that recapitulate the unique liver microenvironment for cell growth create suturable vasculature with proven blood compatibility with resistance to blood clotting and provide strong BIO adhesion to achieve a cohesive biofabricated organ critical for maintaining organ integrity following transplantation. In collaboration with penn state we will evaluate three distinct biofabrication strategies to develop the VITAL liver guided by liver architecture models generated through multi physics simulations. Our goal is to identify the most viable approach for scaling the VITAL liver and demonstrate its full functionality and safety in both mice and pigs. Additionally we will develop a parametric algorithm to generate a branched organ vascular tree which will be packaged into an easy to use open source interface.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Original award | $14,330,656 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Pennsylvania State University | $589,856 |
Quick answers
Who received award D25AC00239?
D25AC00239 was awarded to The University Of Texas Southwestern Medical Center by Interior Business Center (Office of Policy Management and Budget) on September 10, 2025.
How much is award D25AC00239 worth?
$14,330,656 has been obligated on D25AC00239.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award